BRANCHBURG, N.J.--(BUSINESS WIRE)--Hydromer, Inc. (HYDI.OB – OTC BB; HDO - BSX), a New Jersey biotech company publicly traded since 1982, has developed a new biopolymer matrix (F201) with superb lubricity, exceeding over 100 cycles of wet abrasion tests with up to 94% friction reduction. The new polymer is non-cytotoxic with excellent adhesion to PEBAX® Resins, Stainless Steel, Polyurethane and much more. The very first potential application would be in super slippery catheter placement guidewires.
